UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients

British journal of cancer, 2014-03, Vol.110 (6), p.1614-1621

2014

Volltextzugriff (PDF)

Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner

BMC cancer, 2016-08, Vol.16 (1), p.628-628, Article 628

2016

Volltextzugriff (PDF)

Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer

Breast (Edinburgh), 2019-08, Vol.46, p.101-107

2019

Volltextzugriff (PDF)

Whole-genome sequencing of circulating tumor DNA reveals relevance of focal amplifications for the management of metastatic prostate cancer

European journal of cancer (1990), 2016-07, Vol.61, p.S12-S12

2016

Volltextzugriff (PDF)

Long-term cardiovascular complications in stage I seminoma patients

Clinical & translational oncology, 2017-11, Vol.19 (11), p.1400-1408

2017

Volltextzugriff (PDF)

The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy

Clinical biochemistry, 2013-10, Vol.46 (15), p.1585-1589

2013

Volltextzugriff (PDF)

221 Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs

European journal of cancer (1990), 2015-09, Vol.51, p.S33-S33

2015

Volltextzugriff (PDF)

400: Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing

European journal of cancer (1990), 2014-07, Vol.50, p.S96-S96

2014

Volltextzugriff (PDF)

Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

British journal of cancer, 2011-05, Vol.104 (10), p.1641-1648

2011

Volltextzugriff (PDF)

Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?

Histopathology, 2006-12, Vol.49 (6), p.576-581

2006

Volltextzugriff (PDF)

Comparison of total and intact pinp as marker of bone metastases in breast cancer

Bone (New York, N.Y.), 2010-06, Vol.47, p.S113-S114

2010

Volltextzugriff (PDF)

339 - Psychoneuroimmunological predictors of breast cancer progression

Journal of psychosomatic research, 2020-06, Vol.133

2020

Volltextzugriff (PDF)

Psychoneuroimmunological predictors of breast cancer progression

Journal of psychosomatic research, 2020-06, Vol.133, p.110081, Article 110081

2020

Volltextzugriff (PDF)

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells

Clinical chemistry (Baltimore, Md.), 2018-03, Vol.64 (3), p.536-546

2018

Volltextzugriff (PDF)

194P Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study

Annals of oncology, 2023-10, Vol.34, p.S259-S259

2023

Volltextzugriff (PDF)

68P Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism

Annals of oncology, 2020-05, Vol.31, p.S38-S38

2020

Volltextzugriff (PDF)

Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT

Radiology, 2005-02, Vol.234 (2), p.479-485

2005

Volltextzugriff (PDF)

Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report

European journal of gynaecological oncology, 2006, Vol.27 (3), p.297-298

2006

Volltextzugriff (PDF)

1938P Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial

Annals of oncology, 2020-09, Vol.31, p.S1095-S1096

2020

Volltextzugriff (PDF)

Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast

Journal of the National Cancer Institute. Monographs, 2010, Vol.41, p.162-177

2010

Volltextzugriff (PDF)

Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time?

Memo - Magazine of European medical oncology, 2011-12, Vol.4 (4), p.257-259

Bauernhofer, T.

2011

Volltextzugriff (PDF)

Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer

British journal of cancer, 2003-04, Vol.88 (8), p.1301-1309

2003

Volltextzugriff (PDF)

Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

Journal of clinical oncology, 2002-12, Vol.20 (24), p.4621-4627

2002

Volltextzugriff (PDF)

112 - Whole-genome sequencing of circulating tumor DNA reveals relevance of focal amplifications for the management of metastatic prostate cancer

European journal of cancer (1990), 2016-07, Vol.61, p.S12-S12

2016

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(193)
Japanisch
(15)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(107)
Humans
(94)
Female
(66)
Oncology
(61)
Middle Aged
(59)
Aged
(47)
Adult
(45)
Male
(45)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Tumors
(31)
Breast Cancer
(27)
Prognosis
(23)
Breast Neoplasms - Drug Therapy
(19)
Chemotherapy
(18)
Aged, 80 And Over
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Gynecology. Andrology. Obstetrics
(15)
Mammary Gland Diseases
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients

Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner

Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer

Whole-genome sequencing of circulating tumor DNA reveals relevance of focal amplifications for the management of metastatic prostate cancer

Long-term cardiovascular complications in stage I seminoma patients

The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy

221 Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs

400: Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing

Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?

Comparison of total and intact pinp as marker of bone metastases in breast cancer

339 - Psychoneuroimmunological predictors of breast cancer progression

Psychoneuroimmunological predictors of breast cancer progression

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells

194P Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study

68P Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism

Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT

Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report

1938P Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial

Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast

Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time?

Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer

Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

112 - Whole-genome sequencing of circulating tumor DNA reveals relevance of focal amplifications for the management of metastatic prostate cancer

Suchergebnisse filtern